Thus, the CT domain of TMEM106B should be considered a pathogenic protein, and the concept of TMEM106B proteinopathy warrants further analysis both in the context of age‐related changes to TMEM106B and multi‐proteinopathy disorders. This evidence concerns the gene TMEM106B and proteostasis deficiencies.